Paul Tudor Jones's USNA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 70,447 shares of USANA Health Sciences, Inc. (USNA) worth $1.23 M, representing 0.00% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 39 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in USNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 85,570 shares. Largest reduction occurred in Q1 2026, reducing 39,239 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's USANA Health Sciences (USNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly USANA Health Sciences (USNA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -39,239 | Reduce 35.77% | 70,447 | $17.47 |
| Q4 2025 | +85,570 | Add 354.83% | 109,686 | $19.63 |
| Q3 2025 | +24,116 | New Buy | 24,116 | $27.55 |
| Q1 2025 | -9,506 | Sold Out | 0 | $0.00 |
| Q4 2024 | +9,506 | New Buy | 9,506 | $35.89 |
| Q2 2024 | -28,175 | Sold Out | 0 | $0.00 |
| Q1 2024 | -5,731 | Reduce 16.90% | 28,175 | $48.50 |
| Q4 2023 | +33,906 | New Buy | 33,906 | $53.60 |
| Q1 2023 | -12,047 | Sold Out | 0 | $0.00 |
| Q4 2022 | +2,028 | Add 20.24% | 12,047 | $0.05 |
| Q3 2022 | -8,208 | Reduce 45.03% | 10,019 | $56.09 |
| Q2 2022 | +18,227 | New Buy | 18,227 | $72.37 |
| Q4 2021 | -11,170 | Sold Out | 0 | $0.00 |
| Q3 2021 | +3,122 | Add 38.79% | 11,170 | $92.21 |
| Q2 2021 | -12,456 | Reduce 60.75% | 8,048 | $102.39 |
| Q1 2021 | +8,330 | Add 68.42% | 20,504 | $97.59 |
| Q4 2020 | -8,920 | Reduce 42.29% | 12,174 | $77.13 |
| Q3 2020 | +3,084 | Add 17.12% | 21,094 | $73.67 |
| Q2 2020 | +12,847 | Add 248.83% | 18,010 | $73.40 |
| Q1 2020 | +5,163 | New Buy | 5,163 | $57.72 |
| Q3 2019 | -24,530 | Sold Out | 0 | $0.00 |
| Q2 2019 | -7,558 | Reduce 23.55% | 24,530 | $79.41 |
| Q1 2019 | +27,497 | Add 598.93% | 32,088 | $83.86 |
| Q4 2018 | -15,173 | Reduce 76.77% | 4,591 | $117.62 |
| Q3 2018 | +2,126 | Add 12.05% | 19,764 | $120.57 |
| Q2 2018 | +12,578 | Add 248.58% | 17,638 | $115.32 |
| Q1 2018 | +5,060 | New Buy | 5,060 | $85.97 |
| Q4 2017 | -12,791 | Sold Out | 0 | $0.00 |
| Q3 2017 | +8,786 | Add 219.38% | 12,791 | $57.70 |
| Q2 2017 | -10,813 | Reduce 72.97% | 4,005 | $64.17 |
| Q1 2017 | +3,727 | Add 33.60% | 14,818 | $57.63 |
| Q4 2016 | +4,683 | Add 73.08% | 11,091 | $61.22 |
| Q3 2016 | +6,408 | New Buy | 6,408 | $69.13 |
| Q2 2016 | -6,000 | Sold Out | 0 | $0.00 |
| Q1 2016 | -4,600 | Reduce 43.40% | 6,000 | $60.67 |
| Q4 2015 | -200 | Reduce 1.85% | 10,600 | $63.87 |
| Q3 2015 | +10,800 | New Buy | 10,800 | $67.04 |
| Q2 2014 | -16,800 | Sold Out | 0 | $0.00 |
| Q1 2014 | +16,800 | New Buy | 16,800 | $37.68 |
Paul Tudor Jones's USANA Health Sciences Investment FAQs
Paul Tudor Jones first purchased USANA Health Sciences, Inc. (USNA) in Q1 2014, acquiring 16,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held USANA Health Sciences, Inc. (USNA) for 39 quarters since Q1 2014.
Paul Tudor Jones's largest addition to USANA Health Sciences, Inc. (USNA) was in Q4 2025, adding 109,686 shares worth $2.15 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 70,447 shares of USANA Health Sciences, Inc. (USNA), valued at approximately $1.23 M.
As of the Q1 2026 filing, USANA Health Sciences, Inc. (USNA) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in USANA Health Sciences, Inc. (USNA) was 109,686 shares, as reported at the end of Q4 2025.